- Filed
- Mar 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 25, 2025 | 81.55M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 80.36M sh |
| Capex | FY 2024 · Dec 31, 2023 | $32.48K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$210.45K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $1.23M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $890.75K |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $1.49M |
| Current Assets | FY 2024 · Dec 31, 2023 | $2.57M |
| Total Assets | FY 2024 · Dec 31, 2023 | $3.75M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.00 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.00 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $1.3M |
| Net Income | FY 2024 · Dec 31, 2023 | $19.21K |
| Operating Income | FY 2024 · Dec 31, 2023 | $115.29K |
| Gross Profit restated | FY 2024 · Dec 31, 2023 | $1.4M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2023 | $1.71M |
| Revenue | FY 2024 · Dec 31, 2023 | $3.11M |